Pfizer and biontech receive first u.s. fda emergency use authorization of a covid-19 vaccine booster

New york & mainz, germany--(business wire)--pfizer inc. (nyse: pfe) and biontech se (nasdaq: bntx) today announced that the u.s. food and drug administration (fda) has authorized for emergency use a booster dose of the pfizer-biontech covid-19 vaccine for individuals 65 years of age and older, individuals 18 through 64 years of age at high risk of severe covid-19, and individuals 18 through 64 years of age whose frequent institutional or occupational exposure to sars-cov-2 puts them at high ris
BNTX Ratings Summary
BNTX Quant Ranking